ACVC Cardio Talk

Feb 24 2025 12 ep. 13 mins 5
ACVC Cardio Talk Podcast artwork

Experts discussion on the recent data on the usage of a combination of diuretics in AHF patients. Practical tips & tricks for preventing diuretic resistance, avoiding neurohormonal and metabolic overactivity, and individualising therapy depending on electrolyte disturbances, kidney dysfunction or respiratory failure.

  Health & Fitness
RSS feed Share
Copy RSS


Subscribe on Podcast Addict


Catheter-directed therapies for acute pulmonary embolism 

Feb 24 2025 16 mins  
With Milica Aleksic, University Hospital Medical Center Bezanijska Kosa, Belgrade - Serbia, and Andrew Sharp, University College Dublin, Dublin - Ireland. Recent data and trials focusing on catheter-directed thrombolysis and catheterisation techniques in managing acute pulmonary embolism.

Spontaneous coronary artery dissection (SCAD), an emerging cause of acute coronary syndrome

Feb 05 2025 16 mins  
With Sofie Gevaert, University Hospital Ghent, Gent - Belgium, and Fernando Alfonso, La Princesa University Hospital, Madrid - Spain. SCAD: current state of science.

Novel electrical therapies for patients with ADHF: a joint ACVC & EHRA Cardio Talk

Jan 05 2025 16 mins  
With Cecilia Linde, Karolinska Institute, Stockholm - Sweden and Przemyslaw Mitkowski, Poznan University of Medical Sciences, Poznan - Poland. Modern approach to electrotherapy in ADHF: a joint ACVC & EHRA Cardio Talk.

Resuscitated cardiac arrest. What now?

Dec 01 2024 14 mins  
With Janine Poess, Heart Center of Leipzig, Leipzig - Germany, and Christian Hassager, Rigshospitalet, Copenhagen University Hospital, Copenhagen - Denmark. Janine Poess and Christian Hassager discuss prognostication after cardiac arrest.

Echocardiography in the MCS management

Nov 03 2024 12 mins  
With Susanna Price, Royal Brompton Hospital, London - UK and Guido Tavazzi, University of Pavia, Pavia - Italy. Susanna Price and Guido Tavazzi discuss the challenges of echocardiographic assessment in patients with MCS support.

Anticoagulation in MCS

Jul 31 2024 8 mins  
With Hannah Schaubroeck, ICU, Ghent University Hospital - Belgium, and Christophe Vandenbriele, Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London - UK and OLV Hospital, Aalst - Belgium. Challenges associated with the anticoagulation and hemostasis disorders during MCS.

No more beta-blockers after AMI? The results of the REDUCE-AMI trial

Jul 04 2024 13 mins  
With Sean van Depen, University of Alberta, Edmonton - Canada, and Bertil Lindahl, Uppsala University, Uppsala - Sweden. Highlights from the REDUCE-AMI trial.

What have we learned from the DanGer Shock trial?

Jun 02 2024 12 mins  
With David Morrow, Brigham and Women's Hospital, Boston - United States of America & Christian Hassager, Rigshospitalet - Copenhagen University Hospital, Copenhagen - Denmark. Results of a breakthrough study on circulatory support in patients with AMI-CS.

Stress cardiomyopathies in the acute setting- what to do and what not to do

Mar 14 2024 12 mins  
With Guido Tavazzi, University of Pavia, Pavia - Italy & Thomas Lüscher, Royal Brompton Hospital Imperial College London, London - United Kingdom of Great Britain & Northern. Aetiology and management of stress cardiomyopathies in acute settings.

Optimal timing for percutaneous MCS in cardiogenic shock

Nov 28 2023 11 mins  
With Jacob Eifer Moller, Odense University Hospital, Odense - Denmark & Holger Thiele, Heart Center Leipzig at University of Leipzig, Leipzig - Germany.